B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $30
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
B. Riley Securities analyst Anderson Schock maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $20 to $30.
B. Riley Securities analyst Anderson Schock maintains ClearPoint Neuro (NASDAQ:CLPT) with a Buy and raises the price target from $20 to $30.